PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC

Clinical trial NCT00313482 · TERMINATED

Trial details

NCT number: NCT00313482
Sponsor: Veeda Oncology
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Refractory Prostate Cancer

Start date: 2006-04-01
Primary completion: 2008-08-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.